These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
84 related items for PubMed ID: 7634256
21. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease. Berger AK, Duval S, Manske C, Vazquez G, Barber C, Miller L, Luepker RV. Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211 [Abstract] [Full Text] [Related]
22. Evolution of diuretics and ACE inhibitors, their renal and antihypertensive actions--parallels and contrasts. Lant AF. Br J Clin Pharmacol; 1987 Jun; 23 Suppl 1(Suppl 1):27S-41S. PubMed ID: 3034317 [Abstract] [Full Text] [Related]
24. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition. van de Wal RM, Plokker HW, Lok DJ, Boomsma F, van der Horst FA, van Veldhuisen DJ, van Gilst WH, Voors AA. Int J Cardiol; 2006 Jan 26; 106(3):367-72. PubMed ID: 16337046 [Abstract] [Full Text] [Related]
25. [Pathophysiology and treatment of congestive heart failure--recently advanced strategy for heart failure]. Kitabatake A. Hokkaido Igaku Zasshi; 1995 Jan 26; 70(1):9-18. PubMed ID: 7744373 [Abstract] [Full Text] [Related]
26. Critical assessment of ACE inhibitors. Part 2. Howes LG. Aust Fam Physician; 1995 Apr 26; 24(4):639, 641-3. PubMed ID: 7771972 [Abstract] [Full Text] [Related]
28. Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure. McMurray JJ, Pitt B, Latini R, Maggioni AP, Solomon SD, Keefe DL, Ford J, Verma A, Lewsey J, Aliskiren Observation of Heart Failure Treatment (ALOFT) Investigators. Circ Heart Fail; 2008 May 26; 1(1):17-24. PubMed ID: 19808266 [Abstract] [Full Text] [Related]
29. The renin-angiotensin system in the heart and vascular wall: new therapeutic aspects. Falkenhahn M, Gohlke P, Paul M, Stoll M, Unger T. J Cardiovasc Pharmacol; 1994 May 26; 24 Suppl 2():S6-13. PubMed ID: 7898096 [Abstract] [Full Text] [Related]
30. [Left-ventricular hypertrophy as a cardiac risk factor: role of the renin-angiotensin-aldosterone system]. Erne P. Praxis (Bern 1994); 1996 Feb 20; 85(8):227-33. PubMed ID: 8701189 [Abstract] [Full Text] [Related]
36. Control of renal perfusion and function in congestive heart failure. Hollenberg NK. Am J Cardiol; 1988 Sep 09; 62(8):72E-75E. PubMed ID: 3414540 [Abstract] [Full Text] [Related]